Recombinant Mycobacterium bovis cysK Protein ，His & Myc

CysK (cystathionine γ-synthase) is an essential enzyme involved in the transsulfuration pathway, a critical metabolic route that converts homocysteine to cysteine, an important amino acid. The dysfunction of this pathway has been linked to various health issues, including cardiovascular diseases and neurodegenerative disorders. Furthermore, cysteine plays a pivotal role in the synthesis of glutathione, an antioxidant that protects cells against oxidative stress. As such, studying CysK and its recombinant protein provides valuable insights into amino acid metabolism and offers potential therapeutic targets. The production and characterization of recombinant CysK can facilitate the exploration of its enzymatic properties, regulation mechanisms, and interactions with other proteins. Current research is focused on optimizing expression systems to produce high yields of functional CysK, along with investigating its structural characteristics through techniques like X-ray crystallography or nuclear magnetic resonance (NMR). These studies aim to unravel the intricacies of its catalytic mechanism and its role within metabolic pathways, ultimately advancing our understanding of related diseases and supporting the development of clinical interventions. The ongoing research into CysK recombinant proteins promises to contribute significantly to biochemistry and medical sciences, shedding light on how modulating this enzyme could influence metabolic health.